Strides Pharma to conduct trials in India for potential COVID-19 drug

BENGALURU – Indian pharmaceutical company Strides Pharma Science Ltd (SRID.NS) on Thursday received regulatory approval to start clinical trials of antiviral drug favipiravir, which has been touted as a potential treatment for COVID-19. The Bengaluru-based company has received approval from the Drug Controller General of India to conduct […]